Sign In
Buy CRS
$566.85
-11.76 (-2.03%)
At Close: Jul 13, 2026
Is Carpenter Technology (CRS) Stock Outpacing Its Basic Materials Peers This Year?
10:40am, Monday, 13'th Jul 2026
Here is how Carpenter Technology (CRS) and Element Solutions (ESI) have performed compared to their sector so far this year.
Carpenter Stock: Demand Surge Powers Earnings Acceleration As Stock Takes Off
02:57pm, Friday, 10'th Jul 2026
Carpenter stock is testing support at its 21-day moving average after rocketing over 31% in June.
Carpenter Technology (CRS) Crossed Above the 20-Day Moving Average: What That Means for Investors
10:35am, Friday, 10'th Jul 2026
After reaching an important support level, Carpenter Technology (CRS) could be a good stock pick from a technical perspective. CRS surpassed resistance at the 20-day moving average, suggesting a short
Can CRS Achieve Its Upbeat FY26 Operating Income Guidance?
10:55am, Wednesday, 08'th Jul 2026
Carpenter Technology lifts its FY26 operating income outlook after a record third quarter, driven by aerospace and defense demand, pricing, and volume gains.
Carpenter (CRS) Moves to Buy: Rationale Behind the Upgrade
01:01pm, Tuesday, 07'th Jul 2026
Carpenter (CRS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Here's Why Carpenter Technology (CRS) is a Strong Growth Stock
10:45am, Tuesday, 07'th Jul 2026
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Will Carpenter (CRS) Beat Estimates Again in Its Next Earnings Report?
01:10pm, Friday, 03'rd Jul 2026
Carpenter (CRS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Carpenter Technology Announces Conference Call and Webcast
09:00am, Wednesday, 01'st Jul 2026
PHILADELPHIA, July 01, 2026 (GLOBE NEWSWIRE) -- Carpenter Technology Corporation (NYSE: CRS) plans to host a conference call and webcast on Thursday, July 30, 2026 at 10:00 a.m. ET to discuss the resu
3 Reasons Why Growth Investors Shouldn't Overlook Carpenter (CRS)
01:47pm, Tuesday, 30'th Jun 2026
Carpenter (CRS) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Are You Looking for a Top Momentum Pick? Why Carpenter Technology (CRS) is a Great Choice
01:00pm, Friday, 26'th Jun 2026
Does Carpenter Technology (CRS) have what it takes to be a top stock pick for momentum investors? Let's find out.
DelphX Capital Markets Provides Corporate Update on Structured Income Program and CRS Commercialization
07:42pm, Tuesday, 23'rd Jun 2026
Advancing financing partner alignment for BTC Structured Income Program; in active discussions on a pilot transaction with a major U.S. insurer for Credit Rating Securities Toronto, Ontario and New Yo
Carpenter Technology (CRS) is a Top-Ranked Momentum Stock: Should You Buy?
10:51am, Thursday, 18'th Jun 2026
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Poolbeg's European patent win bolsters partnering case before summer trial data, says Cavendish
06:20am, Tuesday, 16'th Jun 2026
Shares in PPoolbeg Pharma PLC (AIM:POLB) rose 3% to 7.8p on Tuesday, taking their gain for the year to date to around 100%, after the drug developer secured a key European patent. The European Paten
Supporting the Mission: Catholic Relief Services Chooses Adstra as a Fundraising Partner
09:00am, Monday, 15'th Jun 2026
PRINCETON, N.J., June 15, 2026 (GLOBE NEWSWIRE) -- Adstra Nonprofit today announced a strategic partnership with Catholic Relief Services (CRS), one of the world's leading humanitarian organizations.
[url="]Genmab A/S[/url] (Nasdaq: GMAB) today announced new data from two studies evaluating epcoritamab, a T-cell engaging antibody administered subcutaneously
